Expert Review of Endocrinology & Metabolism最新文献

筛选
英文 中文
Obesity in type 1 diabetes: an overlooked immune-metabolic issue. 1 型糖尿病患者的肥胖问题:一个被忽视的免疫代谢问题。
IF 3.2
Expert Review of Endocrinology & Metabolism Pub Date : 2024-07-01 Epub Date: 2024-05-06 DOI: 10.1080/17446651.2024.2351868
Ernesto Maddaloni, Dario Tuccinardi
{"title":"Obesity in type 1 diabetes: an overlooked immune-metabolic issue.","authors":"Ernesto Maddaloni, Dario Tuccinardi","doi":"10.1080/17446651.2024.2351868","DOIUrl":"10.1080/17446651.2024.2351868","url":null,"abstract":"","PeriodicalId":12107,"journal":{"name":"Expert Review of Endocrinology & Metabolism","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140853342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Maternal obesity and metabolic (dysfunction) associated fatty liver disease in pregnancy: a comprehensive narrative review. 妊娠期母体肥胖和代谢(功能障碍)相关脂肪肝:综合叙述性综述。
IF 3.2
Expert Review of Endocrinology & Metabolism Pub Date : 2024-07-01 Epub Date: 2024-06-11 DOI: 10.1080/17446651.2024.2365791
Bianca M Leca, Lukasz Lagojda, Chris Kite, Emmanouil Karteris, Eva Kassi, Harpal S Randeva, Ioannis Kyrou
{"title":"Maternal obesity and metabolic (dysfunction) associated fatty liver disease in pregnancy: a comprehensive narrative review.","authors":"Bianca M Leca, Lukasz Lagojda, Chris Kite, Emmanouil Karteris, Eva Kassi, Harpal S Randeva, Ioannis Kyrou","doi":"10.1080/17446651.2024.2365791","DOIUrl":"10.1080/17446651.2024.2365791","url":null,"abstract":"<p><strong>Introduction: </strong>Obesity and metabolic-associated fatty liver disease (MAFLD) during pregnancy constitute significant problems for routine antenatal care, with increasing prevalence globally. Similar to obesity, MAFLD is associated with a higher risk for maternal complications (e.g. pre-eclampsia and gestational diabetes) and long-term adverse health outcomes for the offspring. However, MAFLD during pregnancy is often under-recognized, with limited management/treatment options.</p><p><strong>Areas covered: </strong>PubMed/MEDLINE, EMBASE, and Scopus were searched based on a search strategy for obesity and/or MAFLD in pregnancy to identify relevant papers up to 2024. This review summarizes the pertinent evidence on the relationship between maternal obesity and MAFLD during pregnancy. Key mechanisms implicated in the underlying pathophysiology linking obesity and MAFLD during pregnancy (e.g. insulin resistance and dysregulated adipokine secretion) are highlighted. Moreover, a diagnostic approach for MAFLD diagnosis during pregnancy and its complications are presented. Finally, promising relevant areas for future research are covered.</p><p><strong>Expert opinion: </strong>Research progress regarding maternal obesity, MAFLD, and their impact on maternal and fetal/offspring health is expected to improve the relevant diagnostic methods and lead to novel treatments. Thus, routine practice could apply more personalized management strategies, incorporating individualized algorithms with genetic and/or multi-biomarker profiling to guide prevention, early diagnosis, and treatment.</p>","PeriodicalId":12107,"journal":{"name":"Expert Review of Endocrinology & Metabolism","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141300395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Etiology and emerging treatments for familial chylomicronemia syndrome. 家族性乳糜微粒血症综合征的病因和新疗法。
IF 3.2
Expert Review of Endocrinology & Metabolism Pub Date : 2024-07-01 Epub Date: 2024-06-12 DOI: 10.1080/17446651.2024.2365787
Catherine M Spagnuolo, Robert A Hegele
{"title":"Etiology and emerging treatments for familial chylomicronemia syndrome.","authors":"Catherine M Spagnuolo, Robert A Hegele","doi":"10.1080/17446651.2024.2365787","DOIUrl":"10.1080/17446651.2024.2365787","url":null,"abstract":"<p><strong>Introduction: </strong>Familial chylomicronemia syndrome (FCS) is a rare autosomal recessive condition. Effective treatment is important as patients are at risk for severe and potentially fatal acute pancreatitis. We review recent developments in pharmacologic treatment for FCS, namely biological inhibitors of apolipoprotein (apo) C-III and angiopoietin-like protein 3 (ANGPTL3).</p><p><strong>Areas covered: </strong>FCS follows a biallelic inheritance pattern in which an individual inherits two pathogenic loss-of-function alleles of one of the five causal genes - <i>LPL</i> (in 60-80% of patients), <i>GPIHBP1</i>, <i>APOA5</i>, <i>APOC2</i>, and <i>LMF1</i> - leading to the absence of lipolytic activity. Patients present from childhood with severely elevated triglyceride (TG) levels >10 mmol/L. Most patients with severe hypertriglyceridemia do not have FCS. A strict low-fat diet is the current first-line treatment, and existing lipid-lowering therapies are minimally effective in FCS. Apo C-III inhibitors are emerging TG-lowering therapies shown to be efficacious and safe in clinical trials. ANGPTL3 inhibitors, another class of emerging TG-lowering therapies, have been found to require at least partial lipoprotein lipase activity to lower plasma TG in clinical trials. ANGPTL3 inhibitors reduce plasma TG in patients with multifactorial chylomicronemia but not in patients with FCS who completely lack lipoprotein lipase activity.</p><p><strong>Expert opinion: </strong>Apo C-III inhibitors currently in development are promising treatments for FCS.</p>","PeriodicalId":12107,"journal":{"name":"Expert Review of Endocrinology & Metabolism","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141310438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unmasking the escalation: a comparative analysis of diabetic ketoacidosis severity before and during the COVID-19 pandemic in a Tunisian pioneer study. 揭开升级的面纱:突尼斯先驱研究对 COVID-19 大流行之前和期间糖尿病酮症酸中毒严重程度的比较分析。
IF 3.2
Expert Review of Endocrinology & Metabolism Pub Date : 2024-07-01 Epub Date: 2024-05-16 DOI: 10.1080/17446651.2024.2353723
Asma Gorchane, Taieb Ach, Jihene Sahli, Nassim Bel Hadj Salah, Nadia Ben Lasfar, Asma Ben Abdelkrim, Manel Mallouli, Foued Bellazreg, Wissem Hachfi, Molka Chadli Chaieb, Amel Letaief, Koussay Ach
{"title":"Unmasking the escalation: a comparative analysis of diabetic ketoacidosis severity before and during the COVID-19 pandemic in a Tunisian pioneer study.","authors":"Asma Gorchane, Taieb Ach, Jihene Sahli, Nassim Bel Hadj Salah, Nadia Ben Lasfar, Asma Ben Abdelkrim, Manel Mallouli, Foued Bellazreg, Wissem Hachfi, Molka Chadli Chaieb, Amel Letaief, Koussay Ach","doi":"10.1080/17446651.2024.2353723","DOIUrl":"10.1080/17446651.2024.2353723","url":null,"abstract":"<p><strong>Background: </strong>The severity of diabetic ketoacidosis (DKA) at diagnosis increased during the global COVID-19 pandemic. This study aimed to analyze the impact of the pandemic on the clinical and biological severity of DKA in patients with new-onset diabetes mellitus (DM) in Tunisia.</p><p><strong>Research design and methods: </strong>The study included patients hospitalized for new-onset DKA 2 years prior and 2 years during the COVID-19 pandemic. Data was collected retrospectively, and DKA severity was classified based on biological parameters like potential of hydrogen (pH) and HCO3-.</p><p><strong>Results: </strong>The results showed that DKA was more severe during COVID-19, as evidenced by lower potential of hydrogen (pH) (<i>p</i> = 0.006), and serum bicarbonate (HCO3-) levels (<i>p</i> = 0,005). Despite the higher severity of DKA was higher during COVID-19, intensive care unit hospitalizations remained equivalent (<i>p</i> = 0.359). The prevalence of hyponatremia was also higher during COVID-19 (<i>p</i> = 0.024).</p><p><strong>Conclusion: </strong>The findings suggest that delayed diagnosis and COVID-19 May contribute to the increased severity of DKA and electrolyte imbalance during the pandemic. Further research is needed to better understand the underlying mechanisms and develop appropriate strategies to address this issue.</p>","PeriodicalId":12107,"journal":{"name":"Expert Review of Endocrinology & Metabolism","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140944326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the therapeutic potential of pomegranate juice for uterine relaxation. 探索石榴汁对子宫松弛的治疗潜力。
IF 3.2
Expert Review of Endocrinology & Metabolism Pub Date : 2024-07-01 Epub Date: 2024-03-25 DOI: 10.1080/17446651.2024.2334218
Omar A M Al-Habib, Lina N Adam
{"title":"Exploring the therapeutic potential of pomegranate juice for uterine relaxation.","authors":"Omar A M Al-Habib, Lina N Adam","doi":"10.1080/17446651.2024.2334218","DOIUrl":"10.1080/17446651.2024.2334218","url":null,"abstract":"<p><strong>Background: </strong>The effects of pomegranate juice (PJ) and its components on uterine smooth muscle are unknown. Hence, this study unequivocally demonstrates that pomegranate juice (PJ) significantly impacts myometrial function, providing crucial insights into its relaxant properties and their potential therapeutic applications for uterine-related disorders.</p><p><strong>Research design and methods: </strong>Rat uterine smooth muscle horn strips were suspended in Krebs solution organ baths. Contractions were measured isometrically using a transducer (AD instrument Australia). The effects of PJ were evaluated on contractile activity elicited by potassium chloride (KCl 60 Mm) depolarization. Inhibitors of nitric oxide (L-NAME 3 X 10<sup>-4</sup>), guanylate cyclase (methylene blue 1 X 10<sup>-5</sup>), and Prostaglandin I<sub>2</sub> (indomethacin 3 X 10<sup>-5</sup>), as well as Potassium Channels blockers, were determined.</p><p><strong>Results: </strong>The juice at concentrations from 1.5-5 mg/ml significantly decreased the rat uterine horn contraction induced by KCl. The NO, cGMP, and PGI<sub>2</sub> inhibitors did not block the relaxation response. Furthermore, the PGI<sub>2</sub> inhibitor significantly enhanced the relaxation effects; K<sup>+</sup> channel blockers had no inhibitory effects on the relaxation responses. Contrarily, GLIB improved considerably relaxation.</p><p><strong>Conclusion: </strong>Research suggests pomegranate juice's active ingredient may reduce uterine contractions and treat uterotonic disorders, potentially preventing preterm birth and dysmenorrhea. Further research is needed to determine its mechanism of action.</p><p><strong>Trial registration: </strong>Code: AEC-013.</p>","PeriodicalId":12107,"journal":{"name":"Expert Review of Endocrinology & Metabolism","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140206550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improvements and future perspective in diagnostic tools for neuroendocrine neoplasms. 神经内分泌肿瘤诊断工具的改进和未来展望。
IF 2.7
Expert Review of Endocrinology & Metabolism Pub Date : 2024-07-01 Epub Date: 2024-06-05 DOI: 10.1080/17446651.2024.2363537
Sara Massironi, Marianna Franchina, Davide Ippolito, Federica Elisei, Olga Falco, Cesare Maino, Fabio Pagni, Alessandra Elvevi, Luca Guerra, Pietro Invernizzi
{"title":"Improvements and future perspective in diagnostic tools for neuroendocrine neoplasms.","authors":"Sara Massironi, Marianna Franchina, Davide Ippolito, Federica Elisei, Olga Falco, Cesare Maino, Fabio Pagni, Alessandra Elvevi, Luca Guerra, Pietro Invernizzi","doi":"10.1080/17446651.2024.2363537","DOIUrl":"10.1080/17446651.2024.2363537","url":null,"abstract":"<p><strong>Introduction: </strong>Neuroendocrine neoplasms (NENs) represent a complex group of tumors arising from neuroendocrine cells, characterized by heterogeneous behavior and challenging diagnostics. Despite advancements in medical technology, NENs present a major challenge in early detection, often leading to delayed diagnosis and variable outcomes. This review aims to provide an in-depth analysis of current diagnostic methods as well as the evolving and future directions of diagnostic strategies for NENs.</p><p><strong>Area covered: </strong>The review extensively covers the evolution of diagnostic tools for NENs, from traditional imaging and biochemical tests to advanced genomic profiling and next-generation sequencing. The emerging role of technologies such as artificial intelligence, machine learning, and liquid biopsies could improve diagnostic precision, as could the integration of imaging modalities such as positron emission tomography (PET)/magnetic resonance imaging (MRI) hybrids and innovative radiotracers.</p><p><strong>Expert opinion: </strong>Despite progress, there is still a significant gap in the early diagnosis of NENs. Bridging this diagnostic gap and integrating advanced technologies and precision medicine are crucial to improving patient outcomes. However, challenges such as low clinical awareness, limited possibility of noninvasive diagnostic tools and funding limitations for rare diseases like NENs are acknowledged.</p>","PeriodicalId":12107,"journal":{"name":"Expert Review of Endocrinology & Metabolism","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141247645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The complex web of obesity: from genetics to precision medicine. 肥胖症的复杂网络:从遗传学到精准医学。
IF 3.2
Expert Review of Endocrinology & Metabolism Pub Date : 2024-06-13 DOI: 10.1080/17446651.2024.2365785
Janaki Nair M, Dwaipayan Bharadwaj
{"title":"The complex web of obesity: from genetics to precision medicine.","authors":"Janaki Nair M, Dwaipayan Bharadwaj","doi":"10.1080/17446651.2024.2365785","DOIUrl":"https://doi.org/10.1080/17446651.2024.2365785","url":null,"abstract":"<p><strong>Introduction: </strong>Obesity is a growing public health concern affecting both children and adults. Since it involves both genetic and environmental components, the management of obesity requires both, an understanding of the underlying genetics and changes in lifestyle. The knowledge of obesity genetics will enable the possibility of precision medicine in anti-obesity medications.</p><p><strong>Areas covered: </strong>Here, we explore health complications and the prevalence of obesity. We discuss disruptions in energy balance as a symptom of obesity, examining evolutionary theories, its multi-factorial origins, and heritability. Additionally, we discuss monogenic and polygenic obesity, the converging biological pathways, potential pharmacogenomics applications, and existing anti-obesity medications - specifically focussing on the leptin-melanocortin and incretin pathways. Comparisons between childhood and adult obesity genetics are made, along with insights into structural variants, epigenetic changes, and environmental influences on epigenetic signatures.</p><p><strong>Expert opinion: </strong>With recent advancements in anti-obesity drugs, genetic studies pinpoint new targets and allow for repurposing existing drugs. This creates opportunities for genotype-informed treatment options. Also, lifestyle interventions can help in the prevention and treatment of obesity by altering the epigenetic signatures. The comparison of genetic architecture in adults and children revealed a significant overlap. However, more robust studies with diverse ethnic representation is required in childhood obesity.</p>","PeriodicalId":12107,"journal":{"name":"Expert Review of Endocrinology & Metabolism","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141310440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Temporal trends on the prevalence of renal disease and outcomes among patients with diabetes mellitus hospitalized by heart failure: findings from INCAex. 因心力衰竭住院的糖尿病患者中肾病患病率和预后的时间趋势:INCAex 的研究结果。
IF 3.2
Expert Review of Endocrinology & Metabolism Pub Date : 2024-06-12 DOI: 10.1080/17446651.2024.2365769
José Carlos Arévalo-Lorido, Juana Carretero-Gomez, Alessia Rubini, Francisco Javier Félix-Redondo, Nicolás Roberto Robles Pérez Monteoliva, Miriam Hernández González, Elena Vázquez Jarén, Bárbara Cancho-Castellanos, Reyes González Fernández, Daniel Fernández-Bergés
{"title":"Temporal trends on the prevalence of renal disease and outcomes among patients with diabetes mellitus hospitalized by heart failure: findings from INCAex.","authors":"José Carlos Arévalo-Lorido, Juana Carretero-Gomez, Alessia Rubini, Francisco Javier Félix-Redondo, Nicolás Roberto Robles Pérez Monteoliva, Miriam Hernández González, Elena Vázquez Jarén, Bárbara Cancho-Castellanos, Reyes González Fernández, Daniel Fernández-Bergés","doi":"10.1080/17446651.2024.2365769","DOIUrl":"https://doi.org/10.1080/17446651.2024.2365769","url":null,"abstract":"<p><strong>Background: </strong>To assess 20-year time trends in the prevalence of diabetes mellitus (DM) among inpatients with heart failure (HF) and the influence of coexisting DM and kidney disease (KD) on outcomes.</p><p><strong>Research design and methods: </strong>A retrospective study of patients was admitted due to HF, during the period 2000/2019. The period of follow-up was divided into three intervals according to the European Medical Agency approval of newer hypoglycemic drugs. We analyzed in-hospital mortality and outcomes during the follow-up period.</p><p><strong>Results: </strong>A total of 4959 patients were included. Over time, prevalence of DM was significantly raising among women with HF (50 to 53.2%) and descending among men (50% to 46.8%, <i>p</i> = 0.02). Total mortality and readmissions were higher in patients with DM during the and second periods. However, no significant differences were found in the third-one (HR 1.14, 95% CI 0.94-1.39, <i>p</i> = 0.181). A protector role of oral hypoglycemic medications was observed in this last period. According to the presence of KD, the patients with both DM and KD were who presented most of the events.</p><p><strong>Conclusions: </strong>Over the time analyzed, the prevalence of DM raised among women and decreased among men. DM influenced the prognosis of HF except in the third period when more protective hypoglycemic drugs started to be used.</p>","PeriodicalId":12107,"journal":{"name":"Expert Review of Endocrinology & Metabolism","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141310439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A social movement: mind the gap in women's healthcare and research. 社会运动:关注妇女保健和研究方面的差距。
IF 3.2
Expert Review of Endocrinology & Metabolism Pub Date : 2024-06-10 DOI: 10.1080/17446651.2024.2365790
Lawrence M Nelson
{"title":"A social movement: mind the gap in women's healthcare and research.","authors":"Lawrence M Nelson","doi":"10.1080/17446651.2024.2365790","DOIUrl":"https://doi.org/10.1080/17446651.2024.2365790","url":null,"abstract":"","PeriodicalId":12107,"journal":{"name":"Expert Review of Endocrinology & Metabolism","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141295854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Functional state of the kidneys in patients with acute coronary syndrome against the background of newly identified disorders of carbohydrate metabolism: a multidisciplinary problem. 在新发现的碳水化合物代谢紊乱的背景下,急性冠状动脉综合征患者的肾脏功能状态:一个多学科问题。
IF 3.2
Expert Review of Endocrinology & Metabolism Pub Date : 2024-06-03 DOI: 10.1080/17446651.2024.2363543
Svetlana Kazaryan, Rimma Bazarbekova, Ainur Dossanova, Nazgul Kainarbekova, Aigerim Zhakebayeva
{"title":"Functional state of the kidneys in patients with acute coronary syndrome against the background of newly identified disorders of carbohydrate metabolism: a multidisciplinary problem.","authors":"Svetlana Kazaryan, Rimma Bazarbekova, Ainur Dossanova, Nazgul Kainarbekova, Aigerim Zhakebayeva","doi":"10.1080/17446651.2024.2363543","DOIUrl":"https://doi.org/10.1080/17446651.2024.2363543","url":null,"abstract":"<p><strong>Background: </strong>Determining the relationship between cardiovascular risks, carbohydrate metabolism disorders, and renal dysfunction can help in creating new tools for their management and for better interaction of specialists in a multidisciplinary team. The purpose of this study was to determine the functional state of the kidneys and carbohydrate metabolism in patients with acute coronary syndrome without a history of such disorders.</p><p><strong>Methods: </strong>200 patients of the cardiology department of the City Clinical Hospital No. 7 in Almaty were examined using laboratory diagnostics and subsequent statistical data processing.</p><p><strong>Results: </strong>Acute coronary syndrome develops in 63% of cases against the background of previous disorders of carbohydrate metabolism - prediabetes (45.5%) and type 2 diabetes mellitus (17.5%). In this group of patients, in the presence of disorders of carbohydrate metabolism, in all cases, it is accompanied by acute renal damage. It was noted that diabetes mellitus in newly diagnosed patients actually had a certain duration and occurred much earlier than cardiovascular complications - this was evidenced by an increased level of glycated hemoglobin.</p><p><strong>Conclusions: </strong>Such results indicate the need for early diagnosis of cardio-reno-metabolic syndrome in patients with cardiovascular complications, as well as timely administration of drugs that simultaneously have antidiabetic, cardio- and nephroprotective effects.</p>","PeriodicalId":12107,"journal":{"name":"Expert Review of Endocrinology & Metabolism","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141237052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信